Life style; personal characteristics

Life style; personal characteristics

Characteristics Margins Periods Drug use, 12 years or older Drugs excluding cannabis, laughing gas Last month (%) Drug use, 12 years or older Drugs excluding cannabis, laughing gas Last year (%) Drug use, 12 years or older Drugs excluding cannabis, laughing gas Ever (%) Drug use, 12 years or older Use of laughing gas Last month (%) Drug use, 12 years or older Use of laughing gas Last year (%) Drug use, 12 years or older Use of laughing gas Ever (%) Drug use, 12 years or older Other drugs excluding laughing gas Last month (%) Drug use, 12 years or older Other drugs excluding laughing gas Last year (%) Drug use, 12 years or older Other drugs excluding laughing gas Ever (%) Drug use, 12 years or older Drugs total, excluding laughing gas Last month (%) Drug use, 12 years or older Drugs total, excluding laughing gas Last year (%) Drug use, 12 years or older Drugs total, excluding laughing gas Ever (%)
Total persons Value 2025 . . . 0.1 0.4 6.6 . . . . . .
Total persons Lower bound 95% confidence interval 2025 . . . 0.1 0.3 6.0 . . . . . .
Total persons Upper bound 95% confidence interval 2025 . . . 0.2 0.6 7.2 . . . . . .
Sex: Male Value 2025 . . . 0.2 0.4 8.3 . . . . . .
Sex: Male Lower bound 95% confidence interval 2025 . . . 0.1 0.3 7.4 . . . . . .
Sex: Male Upper bound 95% confidence interval 2025 . . . 0.4 0.7 9.3 . . . . . .
Sex: Female Value 2025 . . . 0.1 0.4 4.9 . . . . . .
Sex: Female Lower bound 95% confidence interval 2025 . . . 0.0 0.2 4.2 . . . . . .
Sex: Female Upper bound 95% confidence interval 2025 . . . 0.2 0.6 5.6 . . . . . .
Age: 0 to 3 years Value 2025 . . . . . . . . . . . .
Age: 0 to 3 years Lower bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 0 to 3 years Upper bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 4 to 11 years Value 2025 . . . . . . . . . . . .
Age: 4 to 11 years Lower bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 4 to 11 years Upper bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 12 to 15 years Value 2025 . . . 0.0 0.2 0.2 . . . . . .
Age: 12 to 15 years Lower bound 95% confidence interval 2025 . . . 0.0 0.0 0.0 . . . . . .
Age: 12 to 15 years Upper bound 95% confidence interval 2025 . . . . 1.2 1.2 . . . . . .
Age: 16 to 19 years Value 2025 . . . 0.7 1.5 3.5 . . . . . .
Age: 16 to 19 years Lower bound 95% confidence interval 2025 . . . 0.2 0.7 2.1 . . . . . .
Age: 16 to 19 years Upper bound 95% confidence interval 2025 . . . 2.4 3.3 5.5 . . . . . .
Age: 20 to 29 years Value 2025 . . . 0.4 1.0 20.8 . . . . . .
Age: 20 to 29 years Lower bound 95% confidence interval 2025 . . . 0.1 0.5 18.3 . . . . . .
Age: 20 to 29 years Upper bound 95% confidence interval 2025 . . . 1.0 1.9 23.4 . . . . . .
Age: 30 to 39 years Value 2025 . . . 0.1 0.6 14.4 . . . . . .
Age: 30 to 39 years Lower bound 95% confidence interval 2025 . . . 0.0 0.3 12.5 . . . . . .
Age: 30 to 39 years Upper bound 95% confidence interval 2025 . . . 0.6 1.3 16.6 . . . . . .
Age: 40 to 49 years Value 2025 . . . 0.1 0.4 5.3 . . . . . .
Age: 40 to 49 years Lower bound 95% confidence interval 2025 . . . 0.0 0.2 4.1 . . . . . .
Age: 40 to 49 years Upper bound 95% confidence interval 2025 . . . 1.0 1.2 6.8 . . . . . .
Age: 50 to 54 years Value 2025 . . . 0.0 0.0 3.2 . . . . . .
Age: 50 to 54 years Lower bound 95% confidence interval 2025 . . . 0.0 0.0 2.0 . . . . . .
Age: 50 to 54 years Upper bound 95% confidence interval 2025 . . . . . 5.0 . . . . . .
Age: 55 to 64 years Value 2025 . . . 0.0 0.1 0.9 . . . . . .
Age: 55 to 64 years Lower bound 95% confidence interval 2025 . . . 0.0 0.0 0.5 . . . . . .
Age: 55 to 64 years Upper bound 95% confidence interval 2025 . . . . 0.5 1.7 . . . . . .
Age: 65 to 74 years Value 2025 . . . 0.0 0.0 0.2 . . . . . .
Age: 65 to 74 years Lower bound 95% confidence interval 2025 . . . 0.0 0.0 0.0 . . . . . .
Age: 65 to 74 years Upper bound 95% confidence interval 2025 . . . . . 0.7 . . . . . .
Age: 75 years or older Value 2025 . . . 0.0 0.0 0.1 . . . . . .
Age: 75 years or older Lower bound 95% confidence interval 2025 . . . 0.0 0.0 0.0 . . . . . .
Age: 75 years or older Upper bound 95% confidence interval 2025 . . . . . 0.7 . . . . . .
Age: 0 to 11 years Value 2025 . . . . . . . . . . . .
Age: 0 to 11 years Lower bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 0 to 11 years Upper bound 95% confidence interval 2025 . . . . . . . . . . . .
Age: 12 to 17 years Value 2025 . . . 0.5 0.9 1.0 . . . . . .
Age: 12 to 17 years Lower bound 95% confidence interval 2025 . . . 0.1 0.4 0.5 . . . . . .
Age: 12 to 17 years Upper bound 95% confidence interval 2025 . . . 1.6 2.0 2.2 . . . . . .
Age: 18 years or older Value 2025 . . . 0.1 0.4 7.0 . . . . . .
Age: 18 years or older Lower bound 95% confidence interval 2025 . . . 0.0 0.2 6.4 . . . . . .
Age: 18 years or older Upper bound 95% confidence interval 2025 . . . 0.2 0.6 7.7 . . . . . .
Origin country: The Netherlands Value 2025 . . . 0.0 0.3 6.8 . . . . . .
Origin country: The Netherlands Lower bound 95% confidence interval 2025 . . . 0.0 0.2 6.1 . . . . . .
Origin country: The Netherlands Upper bound 95% confidence interval 2025 . . . 0.1 0.5 7.5 . . . . . .
Origin country: Europe (excl. NL) Value 2025 . . . 0.0 0.0 6.1 . . . . . .
Origin country: Europe (excl. NL) Lower bound 95% confidence interval 2025 . . . 0.0 0.0 4.4 . . . . . .
Origin country: Europe (excl. NL) Upper bound 95% confidence interval 2025 . . . . . 8.5 . . . . . .
Origin country: outside Europe Value 2025 . . . 0.5 1.0 5.9 . . . . . .
Origin country: outside Europe Lower bound 95% confidence interval 2025 . . . 0.2 0.6 4.7 . . . . . .
Origin country: outside Europe Upper bound 95% confidence interval 2025 . . . 1.1 1.8 7.4 . . . . . .
Origin: born in the Netherlands Value 2025 . . . 0.1 0.5 7.2 . . . . . .
Origin: born in the Netherlands Lower bound 95% confidence interval 2025 . . . 0.1 0.3 6.6 . . . . . .
Origin: born in the Netherlands Upper bound 95% confidence interval 2025 . . . 0.3 0.7 7.9 . . . . . .
Origin: born in NL, parents in NL Value 2025 . . . 0.0 0.3 6.8 . . . . . .
Origin: born in NL, parents in NL Lower bound 95% confidence interval 2025 . . . 0.0 0.2 6.1 . . . . . .
Origin: born in NL, parents in NL Upper bound 95% confidence interval 2025 . . . 0.1 0.5 7.5 . . . . . .
Origin: born in NL, parent(s) abroad Value 2025 . . . 0.7 1.4 10.0 . . . . . .
Origin: born in NL, parent(s) abroad Lower bound 95% confidence interval 2025 . . . 0.3 0.8 8.1 . . . . . .
Origin: born in NL, parent(s) abroad Upper bound 95% confidence interval 2025 . . . 1.6 2.5 12.4 . . . . . .
Origin: born in NL, parent(s) in Europe Value 2025 . . . 0.0 0.0 6.4 . . . . . .
Origin: born in NL, parent(s) in Europe Lower bound 95% confidence interval 2025 . . . 0.0 0.0 3.9 . . . . . .
Origin: born in NL, parent(s) in Europe Upper bound 95% confidence interval 2025 . . . . . 10.4 . . . . . .
Origin: born NL, parent(s) out. Europe Value 2025 . . . 1.0 2.2 12.1 . . . . . .
Origin: born NL, parent(s) out. Europe Lower bound 95% confidence interval 2025 . . . 0.4 1.2 9.5 . . . . . .
Origin: born NL, parent(s) out. Europe Upper bound 95% confidence interval 2025 . . . 2.5 4.0 15.3 . . . . . .
Origin: born abroad Value 2025 . . . 0.1 0.2 3.3 . . . . . .
Origin: born abroad Lower bound 95% confidence interval 2025 . . . 0.0 0.0 2.3 . . . . . .
Origin: born abroad Upper bound 95% confidence interval 2025 . . . 0.8 0.7 4.6 . . . . . .
Origin: born in Europe (excl. NL) Value 2025 . . . 0.0 0.0 5.9 . . . . . .
Origin: born in Europe (excl. NL) Lower bound 95% confidence interval 2025 . . . 0.0 0.0 3.7 . . . . . .
Origin: born in Europe (excl. NL) Upper bound 95% confidence interval 2025 . . . . . 9.1 . . . . . .
Origin: born outside Europe Value 2025 . . . 0.2 0.3 2.0 . . . . . .
Origin: born outside Europe Lower bound 95% confidence interval 2025 . . . 0.0 0.1 1.2 . . . . . .
Origin: born outside Europe Upper bound 95% confidence interval 2025 . . . 1.2 1.1 3.5 . . . . . .
Position: single; < 40 year Value 2025 . . . 0.3 1.6 22.4 . . . . . .
Position: single; < 40 year Lower bound 95% confidence interval 2025 . . . 0.1 0.8 18.8 . . . . . .
Position: single; < 40 year Upper bound 95% confidence interval 2025 . . . 1.3 3.3 26.5 . . . . . .
Position: single; 40 to 64 years Value 2025 . . . 0.3 0.6 5.5 . . . . . .
Position: single; 40 to 64 years Lower bound 95% confidence interval 2025 . . . 0.0 0.2 3.8 . . . . . .
Position: single; 40 to 64 years Upper bound 95% confidence interval 2025 . . . 1.9 2.0 8.0 . . . . . .
Position: single; >= 65 years Value 2025 . . . 0.0 0.0 0.1 . . . . . .
Position: single; >= 65 years Lower bound 95% confidence interval 2025 . . . 0.0 0.0 0.0 . . . . . .
Position: single; >= 65 years Upper bound 95% confidence interval 2025 . . . . . 0.9 . . . . . .
Position: child<18 yrs one-parent Value 2025 . . . 1.7 2.7 3.7 . . . . . .
Position: child<18 yrs one-parent Lower bound 95% confidence interval 2025 . . . 0.2 0.7 1.1 . . . . . .
Position: child<18 yrs one-parent Upper bound 95% confidence interval 2025 . . . 11.3 10.7 11.3 . . . . . .
Positon: child of age, one-parent househ Value 2025 . . . 1.4 2.1 17.3 . . . . . .
Positon: child of age, one-parent househ Lower bound 95% confidence interval 2025 . . . 0.3 0.7 11.6 . . . . . .
Positon: child of age, one-parent househ Upper bound 95% confidence interval 2025 . . . 5.3 6.2 25.1 . . . . . .
Position: child < 18 yrs, two-parents Value 2025 . . . 0.0 0.3 0.3 . . . . . .
Source: CBS.
Explanation of symbols

Table explanation


This table contains data on life style of the Dutch population in private households. These data can be grouped by several personal characteristics.

Data available from: 2014.

Status of the data: final.

Changes by March 13, 2026:
The figures for 2025 have been added. The table has been expanded with information on 'Drug use, excluding cannabis' and 'Use of drugs, total' (in the past month, past year, and ever). Finally, the personal characteristic of poverty (categorized as poor, almost poor, and not poor and not almost poor) has been added.

When will new data be published?
Data on reporting year 2026 will be published in the second quarter of 2027.

Description topics

Drug use, 12 years or older
The questions about drug use are asked to all persons aged 12 or older. The following drug types are asked whether they have ever been used and, if so, when was the last time:
• Cannabis (hashish, weed, marijuana)
• Amphetamine (such as pep and speed)
• XTC (ecstasy, MDMA)
• LSD
• Magic mushrooms (hallucinogenic mushrooms)
• Cocaine (also crack, basecoke, freebase)
• Heroine (horse, smack or brown)
• GHB or GBL
• Methadone (included in the questionnaire up to and including 2022)
• 4-Fluoroamphetamine (4-FA, 4-FMP or Flux) (included in the questionnaire from 2018 up to and including 2022)
• Ketamine (included in the questionnaire from 2023)
• 3-MMC (Poes or 3M) (included in the questionnaire from 2023)
• Laughing gas (figures in the table from reporting year 2023 onwards)
• Other drugs
The answer categories for each type of drug are:
• Yes, in the last 30 days
• Yes, in the last 12 months, but not in the last 30 days
• Yes, more than 12 months ago
• No, never used
Drugs excluding cannabis, laughing gas
Drug use other than cannabis and laughing gas
Based on the questions about the use of:
• Amphetamine (such as pep and speed)
• XTC (ecstasy, MDMA)
• Cocaine (also crack, basecoke, freebase)
• LSD
• Magic mushrooms (hallucinogenic mushrooms)
• Heroine (horse, smack or brown)
• GHB or GBL
• Methadone (included in the questionnaire up to and including 2022)
• 4-Fluoroamphetamine (4-FA, 4-FMP or Flux) (included in the questionnaire from 2018 up to and including 2022)
• Ketamine (included in the questionnaire from 2023)
• 3-MMC (Poes or 3M) (included in the questionnaire from 2023)
• Other drugs
It involves the use of 1 or more of these types of drugs. When using several of these types of drugs, the most recently used type of drug is seen as determining the distribution across the categories 'last month', 'last year' and 'ever'.
Last month
Last year
Ever
Use of laughing gas
Based on the question on the use of laughing gas.
Last month
Last year
Ever
Other drugs excluding laughing gas
Based on the questions about the use of:
• LSD
• Magic mushrooms (hallucinogenic mushrooms)
• Heroine (horse, smack or brown)
• GHB or GBL
• Methadone (included in the questionnaire up to and including 2022)
• 4-Fluoroamphetamine (4-FA, 4-FMP or Flux) (included in the questionnaire from 2018 up to and including 2022)
• Ketamine (included in the questionnaire from 2023)
• 3-MMC (Poes or 3M) (included in the questionnaire from 2023)
• Other drugs
It involves the use of 1 or more of these types of drugs. When using several of these types of drugs, the most recently used type of drug is seen as determining the distribution across the categories 'last month', 'last year' and 'ever'.
Last month
Last year
Ever
Drugs total, excluding laughing gas
Based on the questions about the use of:
• Cannabis (hashish, weed, marijuana)
• Amphetamine (such as pep and speed)
• XTC (ecstasy, MDMA)
• LSD
• Magic mushrooms (hallucinogenic mushrooms)
• Cocaine (also crack, basecoke, freebase)
• Heroine (horse, smack or brown)
• GHB or GBL
• Methadone (included in the questionnaire up to and including 2022)
• 4-Fluoroamphetamine (4-FA, 4-FMP or Flux) (included in the questionnaire from 2018 up to and including 2022)
• Ketamine (included in the questionnaire from 2023)
• 3-MMC (Poes or 3M) (included in the questionnaire from 2023)
• Other drugs
It involves the use of 1 or more of these types of drugs. When using multiple types of drugs, the most recently used type of drug is seen as determining the distribution across the categories 'last month', 'last year' and 'ever'.
Last month
Last year
Ever